🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
101.50
-10.00 (-8.97%)
Nov 20, 2026, 1:30 PM CST

Lotus Pharmaceutical Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7,2597,7406,0301,7711,9831,605
Cash & Short-Term Investments
7,2597,7406,0301,7711,9831,605
Cash Growth
28.03%28.35%240.51%-10.71%23.54%7.82%
Accounts Receivable
8,7806,8637,4356,3844,6513,266
Other Receivables
340.25936.56268.54233.13276.24141.56
Receivables
9,1207,7997,7036,6174,9273,407
Inventory
8,9729,6493,8333,7753,3303,073
Other Current Assets
1,2261,264531.5489.37420.4247.24
Total Current Assets
26,57726,45318,09812,65310,6618,333
Property, Plant & Equipment
7,7717,6073,6663,5113,1482,642
Long-Term Investments
389.36463.883,5943,0482,158301.73
Goodwill
33,35931,9556,1275,6705,6685,586
Other Intangible Assets
12,27512,2045,1995,4875,9102,971
Long-Term Accounts Receivable
110.4113.85122.73152.6--
Long-Term Deferred Tax Assets
14,45413,942486.42411.69390.12310.82
Long-Term Deferred Charges
15,74313,1192,6391,8781,406891.98
Other Long-Term Assets
450.04295.86168.74180.28185.33185.35
Total Assets
111,129106,15440,10132,99229,52621,222

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3,6422,4161,070670.81,403747.55
Accrued Expenses
-2,8511.43.063.570.93
Short-Term Debt
2,4131,6091,615510155.921,377
Current Portion of Long-Term Debt
4,3832,5413,3901,30359.95794.9
Current Portion of Leases
171.25159.6384.3270.2458.9962.47
Current Income Taxes Payable
767.261,416664.47436.56731.15280.16
Current Unearned Revenue
127.25179.16180.9132.85183.08132.01
Other Current Liabilities
8,4855,7071,4321,3983,297931.26
Total Current Liabilities
19,98916,8798,4384,5245,8934,326
Long-Term Debt
51,27250,9058,3849,5198,5964,667
Long-Term Leases
714.33718.62194.06182.246.8243.41
Long-Term Unearned Revenue
10.7516.2926.5645.3365.9285.96
Pension & Post-Retirement Benefits
772.69767.52673.52503.28371.91502.7
Long-Term Deferred Tax Liabilities
1,8941,6971,093721.2448.4304.15
Other Long-Term Liabilities
11,62011,390112.17162.29235.84224.03
Total Liabilities
86,27382,37418,92115,65815,65810,153

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,7002,6692,6592,6502,6262,628
Additional Paid-In Capital
7,7187,6427,4317,1317,5348,039
Retained Earnings
16,29715,90412,6608,9004,8231,701
Treasury Stock
-769.81-824.16-48.39-51.1-57.35-57.75
Comprehensive Income & Other
-1,090-1,610-1,521-1,295-1,058-1,241
Total Common Equity
24,85623,78021,18017,33413,86811,069
Shareholders' Equity
24,85623,78021,18017,33413,86811,069
Total Liabilities & Equity
111,129106,15440,10132,99229,52621,222

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
58,95355,93413,66711,5858,9186,944
Net Cash (Debt)
-51,694-48,194-7,636-9,814-6,935-5,339
Net Cash Growth
------
Net Cash Per Share
-195.22-181.84-28.62-36.97-26.16-20.53
Filing Date Shares Outstanding
266.44266.23268.85267.91265.45265.66
Total Common Shares Outstanding
266.44266.23268.85267.91265.45265.66
Working Capital
6,5889,5749,6608,1294,7684,007
Book Value Per Share
93.2989.3278.7864.7052.2441.67
Tangible Book Value
-20,778-20,3809,8556,1772,2912,512
Tangible Book Value Per Share
-77.98-76.5536.6623.068.639.46
Land
649.88624.65599.33622.55622.31615.49
Buildings
4,1244,0312,0741,8881,3841,313
Machinery
3,7663,6221,8651,8261,5471,408
Construction In Progress
874.26657.97706.38639.411,077675.22
Leasehold Improvements
179.26127.33100.1571.0187.8778.26